Cargando…
Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307085/ https://www.ncbi.nlm.nih.gov/pubmed/37388116 http://dx.doi.org/10.1155/2023/9806393 |
_version_ | 1785065964035899392 |
---|---|
author | and Alternative Medicine, Evidence-Based Complementary |
author_facet | and Alternative Medicine, Evidence-Based Complementary |
author_sort | and Alternative Medicine, Evidence-Based Complementary |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10307085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-103070852023-06-29 Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-06-21 /pmc/articles/PMC10307085/ /pubmed/37388116 http://dx.doi.org/10.1155/2023/9806393 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Retraction and Alternative Medicine, Evidence-Based Complementary Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment |
title | Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment |
title_full | Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment |
title_fullStr | Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment |
title_full_unstemmed | Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment |
title_short | Retracted: Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment |
title_sort | retracted: chemotherapy with a tp regimen in combination with stereotactic radiotherapy could significantly optimize the clinical efficacy of nsclc treatment |
topic | Retraction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307085/ https://www.ncbi.nlm.nih.gov/pubmed/37388116 http://dx.doi.org/10.1155/2023/9806393 |
work_keys_str_mv | AT andalternativemedicineevidencebasedcomplementary retractedchemotherapywithatpregimenincombinationwithstereotacticradiotherapycouldsignificantlyoptimizetheclinicalefficacyofnsclctreatment |